These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 3932088)
21. Potentiation by 1-alpha,25-dihydroxyvitamin D3 of cytotoxicity to HL-60 cells produced by cytarabine and hydroxyurea. Studzinski GP; Bhandal AK; Brelvi ZS J Natl Cancer Inst; 1986 Apr; 76(4):641-8. PubMed ID: 3457201 [TBL] [Abstract][Full Text] [Related]
22. Mechanism of the induction of the differentiation of HL-60 leukemia cells by antifolates. Sokoloski JA; Beardsley GP; Sartorelli AC Cancer Commun; 1989; 1(3):199-207. PubMed ID: 2700913 [TBL] [Abstract][Full Text] [Related]
23. Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies. Kasukabe T; Honma Y; Hozumi M; Suda T; Nishii Y Cancer Res; 1987 Jan; 47(2):567-72. PubMed ID: 3466692 [TBL] [Abstract][Full Text] [Related]
24. Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells. Zheng X; Chang RL; Cui XX; Kelly KA; Shih WJ; Lin Y; Strair R; Suh J; Han ZT; Rabson A; Conney AH Oncol Res; 2000; 12(9-10):419-27. PubMed ID: 11697820 [TBL] [Abstract][Full Text] [Related]
25. Granulocytic differentiation induced by retinoic acid in HL-60 cells is associated with changes in adenylate cyclase activity. Thomas G; Chomienne C; Balitrand N; Schaison G; Abita JP; Baulieu EE Anticancer Res; 1986; 6(4):857-60. PubMed ID: 3092726 [TBL] [Abstract][Full Text] [Related]
26. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines. Levy Y; Knutson JC; Bishop C; Shany S Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403 [TBL] [Abstract][Full Text] [Related]
27. Differential effects of DNA synthesis inhibitors on DNA methylation in normal and transformed cells. de Haan JB; Parker MI Anticancer Res; 1988; 8(4):617-20. PubMed ID: 2845852 [TBL] [Abstract][Full Text] [Related]
28. Induction of differentiation of human myeloid leukemia cells by 2'-deoxycoformycin in combination with 2'-deoxyadenosine. Niitsu N; Umeda M; Honma Y Biochem Biophys Res Commun; 1997 Sep; 238(1):100-6. PubMed ID: 9299460 [TBL] [Abstract][Full Text] [Related]
29. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha. Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050 [TBL] [Abstract][Full Text] [Related]
30. Neplanocin A, a potent inhibitor of S-adenosylhomocysteine hydrolase, potentiates granulocytic differentiation of acute promyelocytic leukemia cells induced by all-trans retinoic acid. Niitsu N; Yamamoto-Yamaguchi Y; Kanatani Y; Shuto S; Matsuda A; Umeda M; Honma Y Exp Hematol; 1997 Nov; 25(12):1296-303. PubMed ID: 9357974 [TBL] [Abstract][Full Text] [Related]
31. Synergistic induction of 1,25-dihydroxyvitamin D(3)- and all-trans-retinoic acid-induced differentiation of HL-60 leukemia cells by yomogin, a sesquiterpene lactone from Artemisia princeps. Kim SH; Kim TS Planta Med; 2002 Oct; 68(10):886-90. PubMed ID: 12391550 [TBL] [Abstract][Full Text] [Related]
32. Induction of a high phagocytic capability in P388D1, a macrophage-like tumor cell line, by 1 alpha, 25-dihydroxyvitamin D3. Goldman R Cancer Res; 1984 Jan; 44(1):11-9. PubMed ID: 6546302 [TBL] [Abstract][Full Text] [Related]
33. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine. Niitsu N; Ishii Y; Matsuda A; Honma Y Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157 [TBL] [Abstract][Full Text] [Related]
34. Recombinant gamma-interferon and lipopolysaccharide enhance 1,25-dihydroxyvitamin D3-induced cell differentiation in human promyelocytic leukemia (HL-60) cells. Murao SI; Fukumoto Y; Katayama M; Maeda H; Sugiyama T; Huberman E Jpn J Cancer Res; 1985 Jul; 76(7):596-602. PubMed ID: 3928556 [TBL] [Abstract][Full Text] [Related]
35. Potentiation of 1-beta-D-arabinofuranosylcytosine cytotoxicity to HL-60 cells by 1,25-dihydroxyvitamin D3 correlates with reduced rate of maturation of DNA replication intermediates. Studzinski GP; Reddy KB; Hill HZ; Bhandal AK Cancer Res; 1991 Jul; 51(13):3451-5. PubMed ID: 2054784 [TBL] [Abstract][Full Text] [Related]
36. Combinations of interferon-gamma and retinoic acid or 1 alpha, 25-dihydroxycholecalciferol induce differentiation of the human monoblast leukemia cell line U-937. Gullberg U; Nilsson E; Einhorn S; Olsson I Exp Hematol; 1985 Aug; 13(7):675-9. PubMed ID: 2411582 [TBL] [Abstract][Full Text] [Related]
37. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells. Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349 [TBL] [Abstract][Full Text] [Related]
38. New facts and speculations on human myeloid leukemias. Breitman TR; Gallo RC Blood Cells; 1981; 7(1):79-89. PubMed ID: 6964818 [TBL] [Abstract][Full Text] [Related]
39. Induction of the differentiation of HL-60 promyelocytic leukemia cells by curcumin in combination with low levels of vitamin D3. Sokoloski JA; Shyam K; Sartorelli AC Oncol Res; 1997; 9(1):31-9. PubMed ID: 9112258 [TBL] [Abstract][Full Text] [Related]
40. Functional interactions between bile acids, all-trans retinoic acid, and 1,25-dihydroxy-vitamin D3 on monocytic differentiation and myeloblastin gene down-regulation in HL60 and THP-1 human leukemia cells. Zimber A; Chedeville A; Abita JP; Barbu V; Gespach C Cancer Res; 2000 Feb; 60(3):672-8. PubMed ID: 10676652 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]